science

SpaceX stock slips as 319 million new shares come to market

Edesa Biotech prices $25M equity offering

Amylyx Pharmaceuticals prices upsized $500M public offering of common stock

NASA said on Wednesday a $30 million mission to save its Swift space telescope had failed after the rescue spacecraft could not be controlled. The unprecedented effort aimed to use a robot to move Swift into a higher orbit. The satellite is now expected to re-enter Earth’s atmosphere and disintegrat

India's Global Capability Centres (GCCs) are assuming control over product ownership and advanced tech initiatives. They are becoming key players in high-level problem-solving and pioneering research and development efforts. By 2026, the AI talent in these centres is expected to nearly double. Addit

Adaptive Biotechnologies CEO Chad Robins sells $14.88m in shares

Pharma groups seek new generation of GLP-1 medicines as some patents start to expire

Trump taps White House adviser Overton to lead FDA

Shares of Moderna and Merck soared on Wednesday morning after a study showed that a vaccine they produced had promising results when it comes to fighting skin cancer. A late-stage trial showed that the mRNA vaccine helped reduce the recurrence of melanoma. Sam Fazeli of Bloomberg Intelligence has mo

The candidate is a combination of an mRNA therapeutic vaccine and Merck’s cancer drug Keytruda.